Is Spravato Right for me?
Spravato® (Esketamine Nasal Spray)
Breakthrough Relief for Treatment-Resistant Depression
Our experienced clinical staff will guide you through the treatment process, from initial consultation to your ongoing sessions, providing a calm, supportive environment that prioritizes your comfort and well-being.
Who is Spravato® for?
Adults with treatment-resistant depression (TRD)
Individuals who have not responded to two or more antidepressants
Patients seeking alternative options after long-term medication trials
What to Expect:
Administered in-office, typically twice weekly to start
Monitored for at least two hours after each session
Combined with an ongoing antidepressant
Comprehensive evaluation and safety screening required
Please note: Spravato® is not administered at home and is only available at certified treatment centers.
FAQs:
-
Many patients report improvements in mood and symptoms within hours or days after their initial Spravato® treatment. However, response times can vary, and it often takes multiple sessions before significant benefits are noticed. Your care team will monitor your progress closely and adjust your treatment plan as needed.
-
Common side effects include dizziness, nausea, dissociation (a feeling of being disconnected from reality), fatigue, and increased blood pressure shortly after treatment. These effects are usually temporary and monitored closely by our clinical staff during and after each session to ensure your safety.
-
After receiving Spravato®, you’ll be observed in our clinic for at least two hours to monitor for any side effects or adverse reactions. During this time, you should not drive or operate heavy machinery. Our staff will ensure you feel stable and comfortable before you leave.
